The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
about
Pathogenesis and management of Kawasaki diseaseSteroid hormone treatment for Kawasaki disease in childrenSteroid hormone treatment for Kawasaki disease in childrenIntravenous immunoglobulin for the treatment of Kawasaki disease in childrenAssociation of Kawasaki disease with tropospheric wind patternsThe Production Processes and Biological Effects of Intravenous ImmunoglobulinKawasaki disease: an updateRe-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapyKawasaki disease: are we missing the diagnosis?Adolescent Kawasaki disease with uveitisComparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndromeTreatment in the pediatric emergency department is evidence based: a retrospective analysisIncomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximabHigh-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki DiseaseA genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease.Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and TreatmentMeta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease.I.v. immune globulin: efficacy and safety.High dose intravenous gammaglobulins in autoimmune disorders: mode of action and therapeutic uses.Kawasaki-like syndromes associated with human immunodeficiency virus infection.Therapeutic strategies in systemic necrotizing vasculitides.Combination therapy in autoimmune disease: vasculitis.Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study.Clinical management and treatment of vasculitis.Treatment of vasculitis.Comparative effectiveness of intravenous immunoglobulin for children with Kawasaki disease: a nationwide cohort study.Kawasaki syndrome hospitalizations and associated costs in the United States.Decreasing fertility rate correlates with the chronological increase and geographical variation in incidence of Kawasaki disease in Japan.Comparison of patients with Kawasaki disease with retropharyngeal edema and patients with retropharyngeal abscess.Coronary artery stenosis risk and time course in Kawasaki disease patients: experience at a US tertiary pediatric centre.Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki diseasePulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology.Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.Late development of coronary artery abnormalities could be associated with persistence of non-fever symptoms in Kawasaki diseaseThe immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease.Kawasaki disease at British Columbia's Children's Hospital.Coronary artery aneurysms--a case study and literature review.
P2860
Q22305933-1DFA84EC-0DF0-403A-B0EE-510C209909CEQ24194442-A6D7319A-1EEC-4F5E-A09C-AF3D5AAA6323Q24242875-6C14A307-C2B7-4000-BAAB-8EB4C32C719EQ24247776-05298318-B230-4232-996C-4F3C56EF23C9Q24627845-4D8526D8-158B-45D0-9FB4-426043A8418BQ26752540-A99FF642-2910-47E0-AC0D-F2F3ADB965F4Q28180597-4D81A7DD-50A6-4193-AB06-D189AE4A6334Q28184382-DFBB720F-FF68-4D1C-8C67-D7A91CC3374FQ28193205-40D53D49-DD27-4C1E-AA5F-0A5155F87745Q28193548-CBF9AD8E-2805-45D3-8E69-2438F8A58C16Q28194044-E0D5A004-DDF2-441B-AC35-06F7DA412FA2Q28200614-9217E90C-CC48-4EFE-87FC-288031BEA9CCQ28222748-E58BF197-81B3-44C6-A597-4F7F733FF968Q28396984-7C8EB29E-682D-4BD0-BA33-BA84DCCFE714Q29417090-8D056E7A-B381-4498-A21B-DB23A21C1F93Q30234397-708F0D05-B50F-419C-B930-9E341E18D718Q33265368-4792CFC9-C1F7-4BDB-B38C-D67F032689C4Q33412730-DEDD0BFF-F73C-46D5-A626-C98BD477FFF0Q33415447-B3EA32B6-543C-41B4-BC6A-CFC1A95A15A5Q34243477-E3EF3B9E-582E-4A49-BEF3-7D2C167760FFQ34267966-DCE3BC5A-9B8A-4A6A-BE6A-ED9A37F81722Q34309769-99AAC79D-FBAD-4FD2-B0D8-D2D4340994CDQ34314065-4B293281-189C-4CE4-B853-2B2BC86F7AF1Q34395174-F5AC1EC7-1617-44D7-B29E-C15AF23E0CBFQ34403507-525B33B9-5704-472F-8F4F-7AAAB0294096Q34708567-625D76D3-D630-451B-B2C8-938C64D2A8D2Q34756420-7FE1854E-5314-432B-9C03-900A1916959DQ34826554-FA4C1BD3-4A5F-4B77-9012-972375CEB874Q35022153-E3CFAC2C-EBAA-4F42-BF54-7A8EEF0A825DQ35204034-8C0023D6-0528-4E99-B2B8-BEFD1C22B903Q35292610-7D62975C-8E78-40AB-8B02-FCC74DA55DA3Q35684461-740A023F-5FB8-4630-9AF0-14FCB781DFFDQ36374231-CB6D8435-B146-4B47-AFC2-EF43AA22D9A4Q36711702-6097DE75-F2C6-4A11-BB0C-21941870246FQ36766177-726747E9-B91C-40E6-A03A-DDE67AF7A7E7Q37071574-45575F28-DE3B-44D8-A7D7-57DFCEBEE282Q37175810-9C0E549A-EF0D-4C92-9160-B2054A8F0CCEQ37272083-26EDA2B4-BEE2-4CD3-B892-A54DD25FE68AQ37289341-916A7EBB-C8D9-4B33-9200-C95F063CC8A3Q37298802-57E4C1DE-85B4-4B19-AFC3-3B4FC65DF553
P2860
The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
description
im August 1986 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 August 1986
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 1986
@uk
name
The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
@en
The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
@nl
type
label
The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
@en
The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
@nl
prefLabel
The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
@en
The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
@nl
P2093
P1476
The treatment of Kawasaki syndrome with intravenous gamma globulin
@en
P2093
Newburger JW
Sanders SP
Takahashi M
P304
P356
10.1056/NEJM198608073150601
P407
P50
P577
1986-08-01T00:00:00Z